Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories
Open Access
- 1 July 2013
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 26 (3), 604-630
- https://doi.org/10.1128/cmr.00016-13
Abstract
SUMMARY Clostridium difficile is a formidable nosocomial and community-acquired pathogen, causing clinical presentations ranging from asymptomatic colonization to self-limiting diarrhea to toxic megacolon and fulminant colitis. Since the early 2000s, the incidence of C. difficile disease has increased dramatically, and this is thought to be due to the emergence of new strain types. For many years, the mainstay of C. difficile disease diagnosis was enzyme immunoassays for detection of the C. difficile toxin(s), although it is now generally accepted that these assays lack sensitivity. A number of molecular assays are commercially available for the detection of C. difficile . This review covers the history and biology of C. difficile and provides an in-depth discussion of the laboratory methods used for the diagnosis of C. difficile infection (CDI). In addition, strain typing methods for C. difficile and the evolving epidemiology of colonization and infection with this organism are discussed. Finally, considerations for diagnosing C. difficile disease in special patient populations, such as children, oncology patients, transplant patients, and patients with inflammatory bowel disease, are described. As detection of C. difficile in clinical specimens does not always equate with disease, the diagnosis of C. difficile infection continues to be a challenge for both laboratories and clinicians.This publication has 278 references indexed in Scilit:
- Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive studyThe Lancet Infectious Diseases, 2012
- Current Status of Clostridium difficile Infection EpidemiologyClinical Infectious Diseases, 2012
- Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2012
- Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Laboratory Diagnosis of Clostridium difficile Infection: Can Molecular Amplification Methods Move Us Out of Uncertainty?The Journal of Molecular Diagnostics, 2011
- Nosocomial Infections in Tbilisi, Georgia: A Retrospective Study of Microbiological Data from 4 Major Tertiary Care HospitalsInfection Control & Hospital Epidemiology, 2011
- Comparison of Five Assays for Detection of Clostridium difficile ToxinThe Journal of Molecular Diagnostics, 2011
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbationProceedings of the National Academy of Sciences of the United States of America, 2010
- Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficileJournal of Hospital Infection, 2009
- The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genomeNature Genetics, 2006